MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY

被引：0
|
作者：
Owen, C. [1 ]
Ngian, G. [1 ]
Moore, O.
Stevens, W.
Proudman, S. [2 ]
Roddy, J. [3 ]
Zochling, J. [4 ]
Nash, P.
Hill, C.
Sturgess, A.
Sahhar, J. [1 ]
机构：
[1] Monash Med Ctr, Clayton, Vic, Australia
[2] Royal Adelaide Hosp, Adelaide, SA, Australia
[3] Royal Perth Hosp, Perth, WA, Australia
[4] Menzies Inst, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2014年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] Mycophenolate Mofetil Versus Azathioprine in Scleroderma-Associated Interstitial Lung Disease: Results from the Australian Scleroderma Cohort Study.
    Owen, Claire
    Ngian, Gene
    Elford, Kathleen
    Moore, Owen
    Nikpour, Mandy
    Stevens, Wendy
    Proudman, Susanna
    Roddy, Janet
    Zochling, Jane
    Hill, Catherine
    Nash, Peter
    Sturgess, Allan
    Sahhar, Joanne
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S740 - S741
  • [2] MYCOPHENOLATE MOFETIL IN THE TREATMENT OF SCLERODERMA-ASSOCIATED DIFFUSE SKIN DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY
    Rajadurai, A.
    Ngian, G.
    Elford, K.
    Stevens, W.
    Proudman, S.
    Roddy, J.
    Nikpour, M.
    Youssef, P.
    Hill, C.
    Sahhar, J.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 37 - 37
  • [3] Effect Of Mycophenolate Mofetil On Scleroderma-Associated Interstitial Lung Disease
    Baqir, M.
    Makol, A.
    Osborn, T. G.
    Bartholmai, B.
    Ryu, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
    Zamora, Ana C.
    Wolters, Paul J.
    Collard, Harold R.
    Connolly, M. Kari
    Elicker, Brett M.
    Webb, W. Richard
    King, Talmadge E., Jr.
    Golden, Jeffrey A.
    [J]. RESPIRATORY MEDICINE, 2008, 102 (01) : 150 - 155
  • [5] Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
    Gerbino, Anthony J.
    Goss, Christopher H.
    Molitor, Jernj A.
    [J]. CHEST, 2008, 133 (02) : 455 - 460
  • [6] THE STABILIZATION OF LUNG FUNCTION IN PATIENTS WITH SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE DURING MYCOPHENOLATE MOFETIL THERAPY
    Koneva, O.
    Ananjeva, L.
    Korzeneva, L.
    Alekperov, R.
    Desinova, O.
    Starovoytova, M.
    Nevskaja, T.
    Ovsjannikova, O.
    [J]. RHEUMATOLOGY, 2012, 51 : 84 - 84
  • [7] Mycophenolate mofetil for interstitial lung disease in scleroderma
    Plastiras, S. C.
    Vlachoyiannopoulos, P. G.
    Tzelepis, G. E.
    [J]. RHEUMATOLOGY, 2006, 45 (12) : 1572 - 1572
  • [8] Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study
    Owen, C.
    Ngian, G-S.
    Elford, K.
    Moore, O.
    Stevens, W.
    Nikpour, M.
    Rabusa, C.
    Proudman, S.
    Roddy, J.
    Zochling, J.
    Hill, C.
    Sturgess, A.
    Tymms, K.
    Youssef, P.
    Sahhar, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (05) : S170 - S176
  • [9] MYCOPHENOLATE MOFETIL VERSUS ORAL CYCLOPHOSPHAMIDE IN SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE: SCLERODERMA LUNG STUDY II
    Khanna, D.
    Roth, M.
    Clements, P.
    Furst, D.
    Tseng, C. -H.
    Elashoff, R.
    Volkmann, E.
    Kafaja, S.
    Goldin, J.
    Tashkin, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 531 - 531
  • [10] Update on scleroderma-associated interstitial lung disease
    Fan, Ming-Hui
    Feghali-Bostwick, Carol A.
    Silver, Richard M.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (06) : 630 - 636
12345